Evidence map›Paper›PMID 11012773›Full record

ArticleImmunology2000

CD5-positive and CD5-negative human B cells converge to an indistinguishable population on signalling through B-cell receptors and CD40.

A Gagro, N McCloskey, A Challa, M Holder, G Grafton, J D Pound, J Gordon

Open access · greenAbstract read
In one paragraph

Article in Immunology, 2000. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 19 papers.

0numbers the graph read from it
0cells of the map it votes in
19citing papers in PubMed
0.7field-weighted citation impact, top 34% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

19 citing papers in PubMed, 44 citations in OpenAlex.

  1. Trial
  2. Placental CD4Exploration of medicine · 2022
    Article
  3. Article
  4. Article
  5. Article
  6. Review
  7. Article
  8. Developmental expression of B cell molecules in equine lymphoid tissues.Veterinary immunology and immunopathology · 2017
    Article
  9. Article
  10. Human B-1 and B-2 B Cells Develop from Lin-CD34+CD38lo Stem Cells.Journal of immunology (Baltimore, Md. : 1950) · 2016
    Article
  11. Article
  12. Article
  13. Review
  14. Article
  15. Article
  16. Killer B lymphocytes: the evidence and the potential.Inflammation research : official journal of the European Histamine Research Society ... [et al.] · 2009
    Review
  17. Article
  18. Article
  19. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 3 institutions in 2 countries.

A GagroThe Medical Research Council Centre for Immune Regulation, University of Birmingham, The Medical School, Birmingham, UK.
N McCloskey
A Challa
M Holder
G Grafton
J D Pound
J Gordon
Medical Research Council · GBUniversity of Birmingham · GBImmune Regulation (United Kingdom) · GB

Funding

Wellcome Trust
6 · The paper itself

Abstract

Whether CD5 on B cells marks a subset functionally distinct from the conventional CD5 negative (CD5neg) adult population or is more an indicator of activation, remains contentious. Here we have investigated whether CD5 positive (CD5pos) and CD5neg B cells can be distinguished in terms of their response to surrogate signals aimed to model, in vitro, T-cell dependent (TD) and T-independent (TI) encounters with antigen in vivo: the predominantly CD5pos B-cell population found in cord blood, CD5 B cells positively selected from tonsils and their CD5neg counterparts, were compared. Neonatal B cells displayed a near-identical phenotype to that of adult CD5pos B cells, being characterized by uniform immunoglobulin M (IgM), immunoglobulin D (IgD), CD23 and CD44 coexpression. When cultured with anti-IgM maintained at high density on CD32-tranfected mouse L cells to model TI responses or on CD40 ligand (CD40L)-bearing L cells (with or without captured anti-IgM) to model TD encounters, DNA synthesis was stimulated to a similar extent in all three populations. Focusing on CD5 and CD23, we found that - although the signals delivered promoted distinct profiles of expression - under each condition of activation, the phenotypes that emerged for adult CD5pos and CD5neg B cells were remarkably similar. Neonatal B cells displayed a greater diminution in CD5 expression than adult CD5pos B cells following CD40 signals but otherwise the two populations again behaved similarly. The inclusion of interleukin-4 (IL-4) to cultures where cells were costimulated via surface (s)IgM and CD40 resulted in a complete loss of CD5 expression and a corresponding hyperexpression of CD23, irrespective of the population studied. The near-identical response of CD5pos and CD5neg B cells to surrogate TD or TI signals in vitro and their convergence to indistinguishable phenotypes is wholly supportive of CD5 being a fluctuating marker of activation rather than it delineating functionally distinct subsets.

Indexed as

AdultAnimalsB-Lymphocyte SubsetsCD40 AntigensCD5 AntigensCell Culture TechniquesCell CycleCell DivisionDNAFetal BloodHumansImmunophenotypingInfant, NewbornLymphocyte ActivationMicePalatine TonsilCD40 AntigensCD5 AntigensDNAReceptors, Antigen, B-Cell

Identifiers

PMID11012773
PMCPMC2327066
OpenAlexW1976951609

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.